Pfizer has informed that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, September 6, 2022, to consider declaration of Interim Dividend for the Financial Year ending March 31, 2023. Further informed that, Pursuant to the 'Pfizer - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders' the Trading Window of the Company shall remain closed from Thursday, September 1, 2022 (close of business) till 48 hours after the
declaration of Interim Dividend, September 8, 2022 (close of business).
The above information is a part of company’s filings submitted to BSE.
